Re-thinking the preclinical development of GBM therapeutics

Oncoscience. 2018 Feb 23;5(1-2):11-12. doi: 10.18632/oncoscience.396. eCollection 2018 Jan.

Authors

Érika Cosset¹, Sara M Weis¹, David A Cheresh¹

Affiliation

¹ Department of Internal Medicine Specialities, Centre of Translational Onco-Hematology, Medical School, University of Geneva, Geneva, Switzerland.

No abstract available

Keywords: Glut3; cancer stem cells; glioblastoma; glucose metabolism; integrin.

Publication types

Editorial